Long‐term efficacy of eculizumab in refractory generalized myasthenia gravis: responder analyses-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Long‐term efficacy of eculizumab in refractory generalized myasthenia gravis: responder analyses

Published:2021-05-27 Issue:7 Volume:8 Page:1398-1407
ISSN:2328-9503
Container-title:Annals of Clinical and Translational Neurology
language:en
Short-container-title:Ann. Clin. Transl. Neurol.

Author:

Howard James F.¹^ORCID,Karam Chafic²,Yountz Marcus³,O’Brien Fanny L.³,Mozaffar Tahseen⁴,

Affiliation:

1. Department of Neurology The University of North Carolina Chapel Hill North CarolinaUSA

2. Department of Neurology Oregon Health & Science University Portland OregonUSA

3. Alexion Pharmaceuticals, Inc. Boston MassachusettsUSA

4. Department of Neurology University of California Irvine CaliforniaUSA

Publisher

Wiley

Subject

Neurology (clinical),General Neuroscience

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/acn3.51376

Reference23 articles.

1. Generalized Myasthenia Gravis

2. Treatment-Refractory Myasthenia Gravis

3. Muscle autoantibodies in myasthenia gravis: beyond diagnosis?

4. Inhibition of acute passive transfer experimental autoimmune myasthenia gravis with Fab antibody to complement C6;Biesecker G;J Immunol,1989

5. C5 gene influences the development of murine myasthenia gravis;Christadoss P;J Immunol,1988

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The efficacy and safety of eculizumab in patients and the role of C5 polymorphisms;Drug Discovery Today;2024-09

2. Distribution and Temporal Changes of Autoantibody-Mediated Pathogenic Mechanisms Among Acetylcholine Receptor-Positive Myasthenia Gravis Patients;2024-08-28

3. Visualization and characterization of complement activation in acetylcholine receptor antibody seropositive myasthenia gravis;Muscle & Nerve;2024-08-08

4. Therapeutic challenges and unmet needs in the management of myasthenia gravis: an Italian expert opinion;Neurological Sciences;2024-07-05

5. Eculizumab Treatment of Massive Hemolysis Occurring in a Rare Co-Existence of Paroxysmal Nocturnal Hemoglobinuria and Myasthenia Gravis;Hematology Reports;2024-04-19

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3